GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amin Pharmaceutical Co (XTEH:AMIN1) » Definitions » Forward Dividend Yield %

Amin Pharmaceutical Co (XTEH:AMIN1) Forward Dividend Yield % : 2.55% (As of May. 27, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Amin Pharmaceutical Co Forward Dividend Yield %?

As of today (2024-05-27), the Forward Annual Dividend Yield of Amin Pharmaceutical Co is 2.55%.

As of today (2024-05-27), the Trailing Annual Dividend Yield of Amin Pharmaceutical Co is 2.55%.

XTEH:AMIN1's Forward Dividend Yield % is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.865 vs XTEH:AMIN1: 2.55

Amin Pharmaceutical Co's Dividends per Share for the six months ended in . 20 was IRR0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Amin Pharmaceutical Co's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Amin Pharmaceutical Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amin Pharmaceutical Co's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amin Pharmaceutical Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Amin Pharmaceutical Co's Forward Dividend Yield % falls into.



Amin Pharmaceutical Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Amin Pharmaceutical Co  (XTEH:AMIN1) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Amin Pharmaceutical Co Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Amin Pharmaceutical Co's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Amin Pharmaceutical Co (XTEH:AMIN1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Abolfazl Street, Bostan Heftam West Alley, No. 4, 2nd floor, Marzdaran, Tehran, IRN
Amin Pharmaceutical Co is engaged in the manufacturing of pharmaceutical products, chemical drugs, herbal medicines, and nutritional supplements. It offers antimicrobials, cardiovascular, antidiabetic, cerebellar, gastrointestinal, antibiotic and antifungal, and hypoglycemic agents among others. It develops drugs in the form of plain and overlaid tablets, hard, and soft capsules, oral drops, syrups, and suspensions. Products offered by the company include Acarbose, Sitagliptin, Fampridine, Ofloxacin, Amiodarone, Ibuprofen, Zolpidem, Bilberry, Thyme, and others. Amin also exports its products to Afghanistan, Kazakhstan, Uzbekistan, and Iraq.

Amin Pharmaceutical Co (XTEH:AMIN1) Headlines

No Headlines